References
- Godsland I. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein(a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001;75:898–915
- Jacobs DR, Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predic-tor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32–47
- Van der Vies J. Pharmacological studies with ORG OD 14. Maturitas 1987;1:15–24
- Ginsburg J, Prelevic GM. The place of tibolone in menopausal therapy. In Studd J, ed. The Manage-ment of the Menopause: The Millenium Review 2000. Carnforth, UK: Parthenon Publishing, 2000:59–67
- Stanczyk FZ. Structure—function relationships, potency, and pharmacokinetics of progestogens. In Lobo RA, ed. Treatment of the Postmeno-pausal Woman. Basic and Clinical Aspects, 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 1999:105–24
- Al-Azzawi F, Wahab M, Habiba M, et al. Contin-uous combined hormone replacement therapy compared with tibolone. Obstet Gynecol 1999; 93:258–64
- Hammer M, Christau S, Nathorst-Boos J, et al. A double-blind randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmeno-pausal women with menopausal symptoms. Br J Obstet Gynaecol 1998;105:904–11
- Nathorst-Böös J, Hammer M. Effect on sexual life — a comparison between tibolone and a continuous estradiol—norethisterone acetate regi-men. Maturitas 1997;26:15–20
- Siseles NO, Haydee H, Haydee HB, et al. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables. Maturitas 1995;21:201–10
- Kökça A, Cetinkaya MB, Yanik F, et al. The comparison of effects of tibolone and conjugated estrogen—medroxyprogesterone acetate therapy on sexual performance in postmenopausal women. Maturitas 2000;36:75–80
- Albertazzi P, Natale V, Barbolini C, et al. The effect of tibolone versus continuous combined norethisterone acetate and estradiol on memory, libido and mood of postmenopausal women: a pilot study. Maturitas 2000;36:223–9
- Castelo-Branco C, Vicente JJ, Figueras F, et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34: 161–8
- Rymer J, Chapman MG, Fogelman I, et al. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994;18: 127–33
- Milner MH, Sinnot MM, Cooke TM, et al. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone andestrogen—progestin. Obstet Gynecol 1996;87: 593–9
- Ginsburg J, Prelevic G, Butler D, et al. Clinical experience with tibolone (Livial®) over 8 years. Maturitas 1995;21:71–6
- Archer DF, Pickar JH. Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding. Obstet Gynecol 2000;96:899–905
- Palacios S, Menendez C, Jrado AR, et al. Changes in sex behavior after menopause: effects of tibolone. Maturitas 1995;22:155–61
- Laan E, van Lunsen RHW, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28–41
- Davis SR, McCloud P, Strauss BJG, et al. Testos-terone enhances estradiol's effects on postmeno-pausal bone density and sexuality. Maturitas 1995;21:227–36
- Sarrel PM. Psychosexual effects of menopause: role of androgens. Am J Obstet Gynecol 1999; 180:S319–24
- Udoff L, Langenberg P, Adashi EY. Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol 1995;86:306–16
- Egarter C, Sator M, Berghammer P, Huber J. Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women. Int J Gynaecol Obstet 1999;64:281–6
- Beardsworth SA, Kearney CE, Purdie DW. Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomized controlled trial. Br J Obstet Gynaecol 1999;106:678–83
- Rymer J, Fogelman I, Chapman MG. The inci-dence of vaginal bleeding with tibolone treat-ment. Br J Obstet Gynaecol 1994;101:53–6